respiratory
Medicines

New treatments bring new lung toxicities in haematology patients


Exciting new therapies for leukaemia and lymphoma are creating a whole new spectrum of complications for pulmonologists and intensivists to deal with, the ERS International Congress was told. Professor Robert Vassallo, from the Division of Pulmonary and Critical Care Medicine at the Mayo Clinic, said patients with haematological malignancies were prone to complications including opportunistic ...

Already a member?

Enter your email to keep reading.


OR